TOP

Research Article

Split Viewer

Mol. Cells 2010; 30(5): 455-460

Published online September 2, 2010

https://doi.org/10.1007/s10059-010-0130-z

© The Korean Society for Molecular and Cellular Biology

Propofol Protects the Autophagic Cell Death Induced by the Ischemia/Reperfusion Injury in Rats

Hae Sook Noh, Il Woo Shin1, Ji Hye Ha, Young-Sool Hah2, Seon Mi Baek, and Deok Ryong Kim*

Department of Biochemistry, Gyeongsang National University School of Medicine, Jinju 660-751, Korea, 1Anesthesiology and Pain Medicine, Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju 660-751, Korea, 2Clinical Research Institute of Gyeongsang National University, Jinju 660-751, Korea

Correspondence to : *Correspondence: drkim@gsnu.ac.kr

Received: June 1, 2010; Revised: July 20, 2010; Accepted: July 29, 2010

Abstract

Autophagy has been implicated in cardiac cell death dur-ing ischemia/reperfusion (I/R). In this study we investi-gated how propofol, an antioxidant widely used for anes-thesia, affects the autophagic cell death induced by the myocardial I/R injury. The infarction size in the myocar-dium was dramatically reduced in rats treated with propofol during I/R compared with untreated rats. A large number of autophagic vacuoles were observed in the cardiomyocytes of I/R-injured rats but rarely in I/R-injured rats treated with propofol. While LC3-II formation, an autophagy marker, was up-regulated in the I/R-injured myocardium, it was significantly down-regulated in the myocardial tissues of I/R-injured and propofol-treated rats. Moreover, propofol inhibited the I/R-induced expression of Beclin-1, and it accelerated phosphorylation of mTOR during I/R and Beclin-1/Bcl-2 interaction in cells, which indicates that it facilitates the inhibitory pathway of autophagy. These data suggest that propofol protects the autophagic cell death induced by the myocardial I/R injury.

Keywords autophagy, Beclin-1/Bcl-2 interaction, cell death, ischemia/reperfusion, propofol

Article

Research Article

Mol. Cells 2010; 30(5): 455-460

Published online November 30, 2010 https://doi.org/10.1007/s10059-010-0130-z

Copyright © The Korean Society for Molecular and Cellular Biology.

Propofol Protects the Autophagic Cell Death Induced by the Ischemia/Reperfusion Injury in Rats

Hae Sook Noh, Il Woo Shin1, Ji Hye Ha, Young-Sool Hah2, Seon Mi Baek, and Deok Ryong Kim*

Department of Biochemistry, Gyeongsang National University School of Medicine, Jinju 660-751, Korea, 1Anesthesiology and Pain Medicine, Institute of Health Sciences, Gyeongsang National University School of Medicine, Jinju 660-751, Korea, 2Clinical Research Institute of Gyeongsang National University, Jinju 660-751, Korea

Correspondence to:*Correspondence: drkim@gsnu.ac.kr

Received: June 1, 2010; Revised: July 20, 2010; Accepted: July 29, 2010

Abstract

Autophagy has been implicated in cardiac cell death dur-ing ischemia/reperfusion (I/R). In this study we investi-gated how propofol, an antioxidant widely used for anes-thesia, affects the autophagic cell death induced by the myocardial I/R injury. The infarction size in the myocar-dium was dramatically reduced in rats treated with propofol during I/R compared with untreated rats. A large number of autophagic vacuoles were observed in the cardiomyocytes of I/R-injured rats but rarely in I/R-injured rats treated with propofol. While LC3-II formation, an autophagy marker, was up-regulated in the I/R-injured myocardium, it was significantly down-regulated in the myocardial tissues of I/R-injured and propofol-treated rats. Moreover, propofol inhibited the I/R-induced expression of Beclin-1, and it accelerated phosphorylation of mTOR during I/R and Beclin-1/Bcl-2 interaction in cells, which indicates that it facilitates the inhibitory pathway of autophagy. These data suggest that propofol protects the autophagic cell death induced by the myocardial I/R injury.

Keywords: autophagy, Beclin-1/Bcl-2 interaction, cell death, ischemia/reperfusion, propofol

Mol. Cells
Sep 30, 2023 Vol.46 No.9, pp. 527~572
COVER PICTURE
Chronic obstructive pulmonary disease (COPD) is marked by airspace enlargement (emphysema) and small airway fibrosis, leading to airflow obstruction and eventual respiratory failure. Shown is a microphotograph of hematoxylin and eosin (H&E)-stained histological sections of the enlarged alveoli as an indicator of emphysema. Piao et al. (pp. 558-572) demonstrate that recombinant human hyaluronan and proteoglycan link protein 1 (rhHAPLN1) significantly reduces the extended airspaces of the emphysematous alveoli by increasing the levels of TGF-β receptor I and SIRT1/6, as a previously unrecognized mechanism in human alveolar epithelial cells, and consequently mitigates COPD.

Share this article on

  • line

Related articles in Mol. Cells

Molecules and Cells

eISSN 0219-1032
qr-code Download